Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference163 articles.
1. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat Rev Drug Discov,2004
2. Overcoming the legal and regulatory barriers to drug repurposing;Breckenridge;Nat Rev Drug Discov,2019
3. Discovery and preclinical validation of drug indications using compendia of public gene expression data;Sirota;Sci Transl Med,2011
4. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets;Cox;Nat Microbiol,2021
5. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia;Toots;Sci Transl Med,2019
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination therapy synergism prediction for virus treatment using machine learning models;PLOS ONE;2024-09-04
2. Effect of cyclosporin A on respiratory viral replication in fully differentiated ex vivo human airway epithelia;Pharmacology Research & Perspectives;2024-08-29
3. A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex;EMBO Reports;2024-06-28
4. Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers;Molecules;2024-03-11
5. Structural Insights into SARS-CoV-2 Nonstructural Protein 1 Interaction with Human Cyclophilin and FKBP1 to Regulate Interferon Production;The Journal of Physical Chemistry Letters;2024-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3